On May 16, the Department of Justice proposed regulations to reschedule cannabis from a Schedule I to a Schedule III substance. The rule would significantly loosen federal restrictions on cannabis, opening new opportunities to industry members, researchers and cannabis users. Still, major questions loom. Join Shareholders Melissa Kuipers Blake and Josh Weiss as they discuss how the rescheduling process will play out, tax implications, what this means for the SAFER Banking bill and many other questions created by this announcement.